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ABSTRACT:  
Background and Aim of the work: Splenectomy is a common operation but it carries the 
danger of many postoperative complications. One of the most important complications is the 
portal vein thrombosis (PVT), which may be fatal due to development of bowel ischemia and 
severe portal hypertension. Due to the effect of hypobaric hypoxia and higher liability for 
thrombosis encountered in high altitude areas, PVT may represent an actual problem in Taif 
province.  The  aim  of  this  retrospective  study  is  to  detect  the  incidence,  pattern  of 
presentation,  laboratory,  radiological  and  results  of  treatment  of  cases  of  PVT  following 
splenectomy. 
Methods: In this study, we reviewed all cases of splenectomy performed in King Abdul Aziz 
Specialist Hospital, Taif, Saudi Arabia from January 2007 to January 2012. Cases of PVT 
following  splenectomy  were  analyzed  for  incidence,  pattern  of  presentation,  laboratory, 
radiological and results of treatment.  
Results: This study involved 50 patients (40 males and 10 females) admitted in the surgical 
department of King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia from January 2007 to 
January 2012. Eight cases of Portal vein thrombosis (16%) out of 50 splenectomies were 
identified.  These  8  patients  included:  4/10  of  the  patients  (40%)  suffering  from 
myeloproliferative (MP), 3 of them (75%) had spleen weight greater than 3,000 g, 3/12 (25%) 
of  the  hemolytic  anemia  patients,  and  1/10  of  the  patients  (10%)  operated  upon  for 
Hypersplenism. All patients had splenomegaly with mean weight of 1540 Gms (range 460 to 
3850 g). Presenting symptoms included; anorexia in 7/8 cases (87.5%), abdominal pain in 6 
(75%), and in all cases there was elevation in D-Dimer level, leukocyte and platelet counts. 
All  diagnoses  were  made  by  contrast-enhanced  computed  tomography  scan,  and 
anticoagulation was initiated immediately. One/8 patients (12.5%) died from progressive liver 
cell failure; the others are alive with no clinical sequalae at a mean follow up of 27 months. 
CONCLUSIONS: PVT is a relatively common complication of splenectomy in patients with 
Splenomegaly,  especially  in  Taif  and  related  districts  in  which  there  is  already  a  higher 
incidence of thrombotic disorders. The surgeon has to be with high index of suspicion, for 
early diagnosis by contrast-enhanced computed tomography, and prompt anticoagulation for 
successful outcome. 
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INTRODUCTION 
 
Portal vein thrombosis (PVT) is a rare but 
serious  complication  of  splenectomy, 
however,  this  low    incidence  may  be 
related to underestimation of the problem 
because  symptoms,  such  as  abdominal 
pain and fever are non-specific and portal 
vein  thrombosis  can  easily  develop 
without  any  symptoms  (Winslow  et  al, 
2005).  Hypercoagulability  after 
splenectomy and stasis of the blood in the 
stump of splenic vein appear to predispose 
to splenic/portal vein thrombosis (SPVT), 
this  hypercoagulability  may  be  due  to 
increased  viscosity  secondary  to  high 
platelet and leucocytes' count as a result of 
absent  splenic  breakdown  (Stamou  et  al, 
2006). Splenectomy is associated also with 
increased rigidity of erythrocytes possibly 
caused  by  accumulation  of  nuclear 
remnants  (Howell  Jolly  bodies)  which 
contributes  to  a  high  plasma  viscosity 
(Phillipe  et  al,  1998).  The  magnitude  of 
this problem may be exaggerated in  high 
altitude  environment  (like  in  Taif 
province)  due  to  the  effect  of  hypobaric 
hypoxia on coagulation system (Bendz et 
al,  2000,  Mubarak  et  al,  2012  and  Al 
Saeed  et  al,  2012).  Identification  of 
patients  with  portal  vein  thrombosis  is 
challenging  to  allow  early  treatment  and 
prevent  potentially  fatal  complications 
such  as  bowel  infarction  or  later  portal 
hypertension  (Dominique  and  Bertrand 
2000). The aim of this retrospective study 
is  to  detect  the  incidence,  pattern  of 
presentation,  laboratory,  radiological  and 
results  of  treatment  of  cases  of  PVT 
following splenectomy.  
PATIENTS  AND  METHODS:  In  this 
retrospective  study,  we  reviewed  the 
hospital  records  of  all  patients  who  had 
splenectomy  performed  in  King  Abdul 
Aziz  Specialist  Hospital,  Taif,  Saudi 
Arabia from January 2007 to January 2012. 
The  study  included  50  patients  and  we 
reviewed the patient files for; age, gender, 
pattern  of  presentation,  laboratory, 
radiological,  results  of  treatment  and 
follow up data if available of the patients 
included in the study.  
Results:  This  study  involved  50  patients 
with  mean  age  of  36  years  (range  9-64) 
and it included forty males and ten females 
(table  1),  admitted  in  the  surgical 
department of King Abdul Aziz Specialist 
Hospital, Taif, Saudi Arabia from January 
2007  to  January  2012.  Eight  cases  of 
Portal  vein  thrombosis  out  of  50 
splenectomies (16%) were identified. The 
incidence of post-splenectomy portal vein 
thrombosis  varies  according  to  the 
indications of splenectomy (table 2) where 
among the 8 patients with PVT included in 
the study, there were; 4 of the 10 patients 
(40%)  underwent  splenectomy  and  were 
suffering  from  myeloproliferative  (MP) 
disease,  3/12  (25%)  of  the  patients  with 
hemolytic anemia, and 1/10 patients (10%) 
operated upon for Hypersplenism. Five/50 
patients  (10%)  developed  PVT  despite Mohamed Al Saeed  
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receiving  prophylactic  subcutaneous 
heparin  postoperatively.  All  patients  had 
splenomegaly  with  mean  weight  of 1540 
Gms  (range  460  to  3850  g).  Three  of  4 
patients (75%) with MP disease and spleen 
weight  greater  than  3,000  g  developed 
PVT. Diagnostic findings are summarized 
in table 3; presenting symptoms included 
anorexia  in  7/8  cases  (87.5%),  vague 
abdominal  pain  in  6  (75%),  fever  in  5/8 
patients (62.5%), nausea and vomiting in 
4/8  patients  (50%)  and  dyspepsia  in  3/8 
patients  (37.5%).  Thrombocytosis  was 
marked  in  all  patients  who  developed 
portal  vein  thrombosis  where  platelet 
count  ranged  from  780,000-1,060,000/ml 
(mean 813,000), while in patients did not 
developed PVT, it ranged from 290,000-
690,000/ml  (mean  480,000).  Leukocyte 
count was high in all patient with mean of 
14,600/c mm. Hemoglobin was high in 3/8 
patients  (37.5%),  normal  in  2/8  patients 
(25%) and low in 3 patients (37.5%) and 
the  mean  hemoglobin  level  was  14.5 
gm/100 ml. D-Dimer level was high in all 
patients  (higher  than  3  μg  fibrinogen 
equivalent units/mL). All  diagnoses  were 
made  by  contrast-enhanced  computed 
tomography  (CT)  scan,  and 
anticoagulation was initiated immediately. 
One/8  patients  (12.5%)  died  from 
progressive liver cell failure; the others are 
alive with no clinical sequalae at a mean 
follow up of 27 months. 
 
 
Table 1: Demographic data. 
Gender  Number of patients (%) 
Male 
Female 
40/50 (80) 
10/50 (20) 
Age  years 
Mean  36 
 
Table 2: Portal vein thrombosis versus the indications of splenectomy 
 
Indication of splenectomy  PVT (%) 
Total number of PVT 
Myeloproliferative disease 
Hemolytic anemia 
Hypersplenism 
 8/50 (16) 
4/10 (40) 
3/12 (25) 
1/10 (10) 
 
 
 Portal Vein Thrombosis after Splenectomy  
 
499  
 
 
Table 3: Diagnosis 
                                Finding    Number of patients (%) 
Anorexia 
Abdominal pain 
Fever 
Nausea & vomiting 
Dyspepsia 
Laboratory tests: 
Thrombocytosis (mean  813,000) 
Leukocytosis (mean 14,600/c mm) 
Hemoglobin  (mean 14.5 gm/100 ml): 
High 
Normal 
Low 
D-Dimer level (> 3 μg fibrinogen equivalent 
units/mL) 
Diagnostic CT (contrast-enhanced) 
     
7/8 (87.5)  
6/8 (75),  
5/8 (62.5),  
4/8 (50)  
3/8 (37.5) 
 
8/8(100)  
8/8(100) 
 
3/8 (37.5) 
2/8 (25) 
3/8 (37.5) 
8/8(100) 
 
8/8(100) 
 
 
DISCUSSION:  
   
The  incidence  of  asymptomatic 
splenic/portal  vein  thrombosis  (SPVT)  is 
not uncommon after splenectomy and it is 
usually  underestimated  due  to 
methodological  variations  and  varying 
degrees  of  clinical  awareness  of  this 
complication  in  contrast  to  DVT/PE, 
where  the  evaluation  of  postoperative 
thrombosis  has  become  highly 
standardized, however, this is not the case 
with  SPVT(Winslow  et  al,  2005).  The 
definition  of  risk  factors  of  thrombo-
embolism  is  important  for  the  choice  of 
intensity  and  duration  of  postoperative 
antithrombotic  prophylaxis,  generally, 
three  groups  of  risk  factors  have  to  be 
considered;  first  is  the  preoperative 
clinical or laboratory risk factors, such as 
age, obesity, previous thrombosis; second, 
the  underlying  disease  (in  particular 
malignant  disease);  and  the  last  are  the 
factors related to the surgical intervention 
itself  including  duration,  open  or 
laparoscopic surgery (Tenconi et al, 2010). 
All these factors are also risk factors for 
SPVT, but in the case of splenectomy the 
type  of  the  underlying  disease  and  the 
spleen size seem to be by far the highest 
risk factor as seen in the patients with big 
spleens, suffering from myeloproliferative Mohamed Al Saeed  
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(MP)  diseases,  lymphoma  and  patients 
with  hemolysis,  in  particular  hereditary 
hemolytic  anemia  (Mohren  et  al,2004). 
Petit  et al, (1994) in a prospective study 
with the use of US and CT, found that 13 
cases (10.9%) complicated by SPVT after 
splenectomy.  In  the  present  study  we 
found  that  the  incidence  of  PVT  after 
splenectomy was significantly higher than 
that of other studies, 8/50 patients (16%), 
this higher incidence may be attributed to 
the  high  incidence  of  splenectomy  in 
blood  diseases  and  may  be  related  to 
environmental factors where high altitude 
may  play  an  important  rule  due  to  the 
effect of hypobaric hypoxia on coagulation 
system and in particular, increased factor 
VIIa  activity,  in  addition  to  dehydration, 
polycythemia  and  vascular  spasms  may 
lead  to  a  higher  liability  for  thrombosis 
(Bendz  et  al,  2000,  Mubarak  et  al,  2012 
and Al Saeed et al, 2012). Blood diseases 
represent  the  main  indication  of 
splenectomy  in  many  studies,  Phillipe  et 
al, (1998) reported that most of the cases 
of  PVT  after  splenectomy  were  due  to 
blood  diseases  with  considerable 
percentage in females. Similar results were 
reported  by  Chaffanjon  et  al,  (1998),  in 
their  study  of  60  patients  who  had 
splenectomy  for  hematological  diseases 
they  found  that  3  (5%)  developed 
asymptomatic  PVT.  In  our  study  4/10 
patients (40%) who had myeloproliferative 
(MP) disease  developed PVT (3 of them 
(75%)  had  spleen  weight  greater  than 
3,000 g) PVT is also seen in 3/12 (25%) 
with  hemolytic  anemia,  and  in  1/10 
patients  (10%)  operated  upon  for 
hypersplenism.  
 It has been stated that the same rules for 
postoperative  thrombosis  prophylaxis 
should  be  applied  for  Splenectomy,  but, 
most  of  the  studies  concentrated  on  the 
risk of postoperative DVT/PE and did not 
consider  the  risk  of  SPVT  though  the 
incidence of asymptomatic SPVT seems to 
be  significantly  higher  than  that  of 
DVT/PE  (Stamou  et  al,  2006).  Several 
cases  of  SPVT  have  been  described  in 
patients despite prophylaxis with standard 
or low molecular weight heparin (Geerts et 
al,  2004).  This  study  showed  that  5/50 
patients  (10%)  developed  PVT  despite 
receiving  prophylactic  subcutaneous 
heparin  postoperatively  and  represented 
62.5% (5/8) of all patients developed this 
complication; however, this may be related 
to short duration of therapy. In this series 
vague  abdominal  pain  was  the  most 
common symptom of patients followed by 
fever, nausea and vomiting in addition to 
that  Leukocytosis  was  present  in  all 
patients.    These  data  are  vague  and  non 
specific but comparable to that reported in 
other  studies  (Winslow  et  al,  2005). 
Secondary  polycythemia  was  seen  in 
37.5%  of  patients  (3/8)  and  the  mean 
hemoglobin  level  was  14.5  gm/100  ml, 
however,  these  cases  of  polycythemia 
must be put in consideration especially in 
patients  living  in  high  altitude 
environment. Thrombocytosis was marked 
in all patients who developed portal vein Portal Vein Thrombosis after Splenectomy  
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thrombosis  where  platelet  count  ranged 
from  780,000-1,060,000/  ml  (mean 
813,000),  while  in  patients  did  not 
developed PVT, it ranged from 290,000-
690,000 / ml (mean 480,000). Mesa et al, 
(2006)  concluded  that  following 
splenectomy; thrombocytosis is one of the 
most  important  predisposing  factors  for 
S/PTV  and  he  advised  antithrombotic 
prophylaxis  if  the  platelet  count  exceeds 
one million and even if less in presence of 
other risk factor(s).  In the present study, 
D-Dimer  level  was  high  in  all  patients 
(higher  than  3  μg  fibrinogen  equivalent 
units/mL),  however,  several  studies  have 
shown that D-Dimer assay would have a 
high  negative  predictive  value,  and  this 
test  may  be  useful  for  the  exclusion  of 
patients  with  suspected  mesenteric/portal 
vein  thrombosis  (Altinyollar  et  al,  2006 
and Yu Zhang et al, 2012). 
      In  most  of  the  studies  color  duplex 
imaging  was  the  screening  method  of 
choice,  but  it  is  now  well  known  that 
contrast  enhanced  CT  is  more  sensitive 
and In fact, the incidence of SPVT was at 
least twice as high when contrast enhanced 
CT  was  used  for  screening  or  diagnosis 
(Bradbury,  et  al  2002).  In  this  study  all 
cases of PVT were confirmed by contrast 
enhanced CT after performing initial color 
duplex  whilst,  routine  Ultrasonography 
was often of restricted value due to bowel 
distension in the early postoperative days 
so,  no  accurate  diagnosis  could  be 
achieved. 
   After  diagnosis  of  portal  vein 
thrombosis,  prompt  initiation  of  therapy 
seems to be an important determinant for 
success and different regimen of treatment 
was used (Dominique and Bertrand 2000). 
In  the  present  study  anticoagulation  was 
initiated  immediately  with  good response 
and  7/8  patients  (87.5%)  responded  with 
complete  or  partial  recanalization  at  a 
mean  follow  up  of  27  months.  one/8 
patients  (12.5%)  died  from  progressive 
liver  cell  failure.  These  findings  are 
coincident with that of other studies where 
recanalization  can  be  achieved  with 
anticoagulant therapy in more than 80% of 
patients (Riet et al., 2000).   
 
CONCLUSIONS:  PVT  is  a  relatively 
common  complication  of  splenectomy  in 
patients  with  Splenomegaly  especially  in 
Taif and related districts in which there is 
already  a  higher  incidence  of  thrombotic 
disorders. The surgeon has to be with high 
index of suspicion, for early diagnosis by 
contrast-enhanced  computed  tomography, 
and prompt anticoagulation for successful 
outcome. 
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يبرعلا صخلملا  
لاحطلا لاصئتسا دعب يبابلا ديرولا ةطلج  
د / ديعسلا دمحم  
 ةيدوعسلا ةيبرعلا ةكلمملا ،فئاطلا ةعماج بطلا ةيلك ةحارجلا مسق  
 
ثحبلا نم فدهلاو ةمدقم :    مظعمل لثملأا لحلا دعت ام اريثك يتلاو ةعئاشلا تايلمعلا نم لاحطلا لاصئتسا نإ
 ديرولا ةطلج اهرطخأ نم يتلاو تافعاضملا نم ديدعلا ةيلمعلا هذه نع جتني دقو لاحطلا تاباصأو ضارمأ
 ةيبابلا ةرودلا يف طغضلا عافترا اهنع جتني ثيح ضيرملا ةايح ىلع ارطخ لثمت دق يتلاو يبابلا  ىلإ يدؤت دقو
 لاصئتسا دعب يبابلا ديرولا ةطلج تلااح مييقت ةساردلا هذه نم فدهلا ناكو تلااحلا ضعب يف ءاعملأا ءاشتحا
هجلاعو هيصخشت قرطو ضرملا ثودح ةبسن ثيح نم لاحطلا   .  
 
بيلاسلااو ىضرملا :    اضيرم نيسمخ ةساردلا هذه تلمش دقو  ( ثانلاا نم ةرشعو روكذلا نم نيعبرأ  )  ثيح  مت
 دبع كلملا يفشتسمب ةماعلا ةحارجلا مسقب لاحطلا لاصئتسلا هحارج مهل ءارجأ مت نيذلا ىضرملا تافلم صحف
 رياني نيب ام ةرتفلا يف فئاطلاب زيزعلا 7002    رياني ىلإ 7007    هيصخشت قرطو ضرملا ثودح ةبسن ثيح نم
هجلاعو .  
 
جئاتنلا :    فاشتكا ةساردلا هذه ةجيتن تناكو 8    ىضرم ( 01  )% صم  لاصئتسا دعب ىبابلا ديرولا ةطلجب نيبا
 لاحطلا يف حضاو مخضت اهب دجو يتلا تلااحلا اهمها لماوع ةدع ىلإ عجرتو ةيلاع ةبسنلا هذه دعتو لاحطلا
 لماوعلا ىلا ةفاضلااب لاحطلا لاصئتسا دعب ةيومدلا حئافصلا ددع ةدايز وا مدلا ضارملا بحاصملا ةصاخبو
ةعفترملا قطانملا ىف ةيئيبلا  .  
 انايحأو مضهلا رسع ،نطبلاب ملاآو ةرارحلا ةجرد يف عافترا نم يناعت يبابلا ديرولا ةطلج تلااح نأ دجو دقو
 نأ دجو ةغبصلا مادختسا عم ةيعطقملا ةعشلااو نولملا رلبودلا زاهج ةطساوب يضرملا لك صحفبو ئقلل ليم 8  
 يضرملا ءلاؤه جلاع مت دق و يبابلا ديرولا يف ةطلج مهب ىضرم  نأ ثيح راظتنا نود ةطلجلا صيخشت درجمب
ةطلجلا كلت ةروطخ ضيرملا بنجيو ةديج جئاتن يطعي جلاعلا .  
 
ةمتاخ :   يبابلا ديرولا ةطلج نا    مخضت نم نوناعي نيذلا ىضرملا يف لاحطلا لاصئتسا دعب ايبسن عئاش ضرم
 تقو يف ضرملا صيخشتل اهبتنم نوكي نا حارجلا ىلع بجيو اهلوح قطانملاو فئاطلا يف اصوصخو لاحطلا
ةيضرم ةجيتن ىلع لصحيل اروف مدلا رثخت عناوم ءاطعاو ةغبصلا عم يعطقملا ريوصتلا ةطساوب ركبم .  